Articles From: Realty Income Declares Preferred Stock Monthly Dividends to Intellipharmaceutics Announces Update on Its Generic Versions of Keppra XR(R) and Pristiq(R)

Realty Income Corporation (Realty Income), The Monthly Dividend Company ® , (NYSE:O) , today announced that its Board of Directors declared dividends on the Company’s Monthly Income Class E and Class F preferred stock.

The Law Offices of Todd M.

Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all purchasers of the common stock of Cirrus Logic, Inc. (“Cirrus” or the “Company”) (NASDAQ: CRUS) between July 31, 2012 and October 31, 2012, inclusive (the “Class Period”). Cirrus develops signal-processing integrated circuits for audio and energy markets.

Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court, Northern District of California on behalf of all purchasers of the common stock of VeriFone Systems, Inc. (“VeriFone” or the “Company”) (NYSE:PAY) between December 14, 2011 and February 19, 2013, inclusive (the “Class Period”). VeriFone designs, markets, and services electronic payment solutions worldwide.

Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court, Northern District of California on behalf of all those who purchased common stock of Epocrates, Inc. (“Epocrates” or the “Company”) (NASDAQ:EPOC) between February 2, 2011 and August 9, 2011, inclusive (the “Class Period”). The complaint alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company's pharmaceutical clients were awaiting guidance from the FDA relating to advertising on the Internet and through social media; (2) these clients were increasingly delaying their marketing activities; (3) the FDA's delay in issuing guidance was causing expanding regulatory queues for Epocrates; (4) these queues were negatively impacting the Company's sales and revenue growth; and

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0859856001&sourceType=1 http://www.ccnmatthews.com/logos/20110221-red_reg.jpg VANCOUVER, BRITISH COLUMBIA --

High Arctic Reports $39.6 Million in Adjusted EBITDA for 2012 Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

NPR reports fourth quarter and full year 2012 financial results.

The Law Offices of Todd M.

The Law Offices of Howard G.

http://media.marketwire.com/attachments/200910/443462_PutnamLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=996450&ProfileId=051205&sourceType=1 BOSTON, MA --

Glancy Binkow & Goldberg LLP announces that it is investigating potential claims against ITT Educational Services, Inc. (“ITT” or the “Company”) (NYSE:ESI) concerning possible violations of federal securities laws.

NEW ORLEANS, March 13, 2013 (GLOBE NEWSWIRE) -- EPL Oil & Gas, Inc. (EPL or the Company) (NYSE:EPL) will present at the 41 st Annual Howard Weil Energy Conference on Wednesday, March 20, 2013 at 1:40 p.m. Central time in New Orleans.

Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court, Northern District of California on behalf of all purchasers of the common stock of Impax Laboratories, Inc. (“Impax” or the “Company”) (NASDAQ:IPXL) between June 6, 2011 and March 4, 2013, inclusive (the “Class Period”). Impax is a specialty pharmaceutical company involved in the development, manufacture, and marketing of bioequivalent pharmaceutical products and branded products.

New Source Energy Partners L.P., a Delaware limited partnership (NYSE: NSLP) (the “Partnership”), announced today that underwriters of its recently completed initial public offering have purchased an additional 250,000 common units at $20.00 per unit granted to them in the Underwriting Agreement dated February 7, 2013.

Gramercy Capital Corp.

The Law Offices of Howard G.

The Law Offices of Todd M.

Law Offices of Howard G.

http://media.marketwire.com/attachments/201003/3344_Clipboard01.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=996432&ProfileId=051205&sourceType=1 GEORGE TOWN, GRAND CAYMAN, CAYMAN ISLANDS --

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=996433&ProfileId=051205&sourceType=1 MEDFORD, OR --

Vista Gold Corp.

DENVER , March 13, 2013 /PRNewswire/ -- Vista Gold Corp.

WUHAN CITY, China, March 13, 2013 /PRNewswire/ -- Tianli Agritech, Inc. (NASDAQ:  OINK ) ("Tianli" or the "Company"), a leading producer of breeder hogs and market hogs based in Wuhan City, China, today announced that it will hold its fourth quarter and full year 2012 financial results conference call at 8:00 am EDT on Friday, March 15, 2013.

HOUSTON, March 13, 2013 (GLOBE NEWSWIRE) -- NightCulture Inc. (the "Company") (OTCBB:NGHT) is pleased to announce its partnership with SXSW and Disco Donnie Presents on five showcase Electronic Music events.

Granite City Food & Brewery Ltd.

Closes Public Offering of $1.5 Billion in Notes Enters into $1 Billion Unsecured Revolving Credit Agreement NEW YORK , March 13, 2013 /PRNewswire/ -- Avon Products, Inc. (NYSE: AVP) today announced that the company has completed refinancing activities, including the completion of a public offering of $1.5 billion in notes.

Survey underscores need to educate young people so they recognize signs of dating abuse and learn how to safely intervene in abusive situations Greene also announces new grants to expand m.powerment by mark.

WaterFurnace Renewable Energy, Inc. Fiscal Year & 4th Quarter Results Canada NewsWire Increased margins, strong cash position and renewed optimism for residential new construction.

TORONTO, March 13, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced an update on its generic versions of the marketed drugs Keppra XR® and Pristiq®. In September of 2012, the Company announced that it had filed with the U.S. Food and Drug Administration (" FDA ") two Abbreviated New Drug Applications (" ANDAs "), for generic versions of the marketed drugs Keppra XR® (levetiracetam extended-release tablets), an antiepileptic product for the treatment of partial onset seizures in patients with epilepsy and Pristiq® (desvenlafaxine extended-release tablets), a product for the treatment of depression.